Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (33144)	3/3/2000 4:28:00 PM
From: Popiye	Read Replies (1) \| Respond to of 150070

"All this humble talk of $8 is getting me very interested." Yes, we all can be humble with a xxx banger (LOL) no pun intended. Best wishes:)

To: Jim Bishop who wrote (33144)	3/3/2000 4:34:00 PM
From: myturn	Read Replies (1) \| Respond to of 150070

Jimmie B., check out ASET. Please give me your thoughts on it. That wasn't me who bought those 3k today. I have it on my watchlist.

To: Jim Bishop who wrote (33144)	3/3/2000 5:03:00 PM
From: Fred C. Dobbs	Respond to of 150070

STS.V still halted, but at least an impact date. Friday, March 03, 2000 To Acquire Controlling Interest in an Israeli Medical Technology Co. March 3, 2000 via CDS Harry Z. Bristman, Chairman & CEO of Starpoint Goldfields Inc. is pleased to announce the Company has completed due diligence on the Israeli medical technology company, and have reached an agreement in principal to acquire a 51% equity in Labour Control Systems Ltd. for US$3.5 million. The Haifa based company is arms length to Starpoint and its principals. It develops products using fibre-optic probes for use in the medical field. Already at an advanced stage of development and testing, the Israeli company will market worldwide vital sign fetal monitoring equipment which reduces infection and provides more accurate data during labour before childbirth. The probes complements fetal monitoring and represents a unique scientific breakthrough with universal application. A formal contract remains to be signed, and is expected to occur on or before March 22, 2000. Terms will include an exchange of directors with payments and the equity interest acquired to be made in stages over a period of two years. The Company has made one initial payment of $100,000USD and a further payment of $100,000USD is to be made on or before May 1, by which time the Company anticipates receiving regulatory acceptance to the transaction. The Company will remain halted until it satisfies Canadian Venture Exchange 'Change of Business' requirements including securing a member sponsor. Completion of the transaction is also subject to a number of conditions, including but not limited to, Exchange acceptance and shareholder approval. Investors are advised that there can be no assurance that the transaction will be completed as proposed or at all. CONTACT: TEL: (604) 988-3600 Starpoint Goldfields Inc. FAX: (604) 988-3605 Harry Z. Bristman, Chairman & C.E.O. EMAIL:sts@starpoint.com cdnx.ca. stockhouse.com newsheadquarters.com newsheadquarters.com. Just finished a PP of 1,000,000 @ 0.26 O/S 15 million